Nykode Therapeutics ASA (NYKD) — Cash Flow Quality Index
Nykode Therapeutics ASA (NYKD) has a Cash Flow Quality Index of 1.91x as of December 2021. Operating cash flow of Nkr180.92 Million exceeds net income of Nkr94.90 Million, indicating high earnings quality where cash backs reported profits. Explore cash flow conversion of Nykode Therapeutics ASA to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Nykode Therapeutics ASA Cash Flow Quality Index (2020–2020)
Historical Cash Flow Quality Index for Nykode Therapeutics ASA across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check NYKD cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Nykode Therapeutics ASA (2020–2020)
Year-by-year earnings quality comparison for Nykode Therapeutics ASA. For live market cap and the full company financial profile, see NYKD market cap.
| Year | Quality Index | Operating CF (NOK) | Net Income | YoY Change |
|---|---|---|---|---|
| 2020 | 1.00x | Nkr180.27 Million | Nkr180.91 Million | — |